Hikma Pharmaceuticals Plc Notice of Results

Data : 04/02/2020 @ 10:07
Fonte : UK Regulatory (RNS & others)
Titolo : Hikma Pharmaceuticals Plc (HIK)
Quotazione : 2562.0  47.0 (1.87%) @ 17:35
Quotazione Hikma Pharmaceuticals Grafico

Hikma Pharmaceuticals Plc Notice of Results

Grafico Azioni Hikma Pharmaceuticals (LSE:HIK)
Storico


Da Nov 2019 a Mag 2020

Clicca qui per i Grafici di Hikma Pharmaceuticals

TIDMHIK

RNS Number : 8920B

Hikma Pharmaceuticals Plc

04 February 2020

London, February 4, 2020 - Hikma Pharmaceuticals PLC (Hikma, Group / LSE: HIK / NASDAQ Dubai: HIK / OTC: HKMPY) (rated Ba1/stable Moody's and BB+/positive S&P), will announce its preliminary financial results for the year ended 31 December 2019 on Thursday 27 February 2020.

A presentation and webcast for analysts will be held on 27 February 2020 at 9:30am GMT, for further information about the meeting, please get in contact with Tiina Lugmayer - Tiina@Hikma.uk.com.

To join via conference call please dial:

United Kingdom 0800 640 6441

United Kingdom (local) 020 3936 2999

All other locations +44 20 3936 2999

Access code: 442936

The results presentation and a webcast recording of the event will be available on the Company's website at www.hikma.com or https://webcast.openbriefing.com/hikma-prelim2019/.

Playback facility:

A playback of the conference call will be available up to six months after the presentation.

UK: 020 3936 3001

USA: 1 845 709 8569

All other locations: +44 20 3936 3001

Access code: 169303

- ENDS -

Enquiries

Hikma Pharmaceuticals PLC

 
 Susan Ringdal 
  EVP, Strategic Planning and Global    +44 (0)20 7399 2760/ +44 7776 
  Affairs                                477050 
 

FTI Consulting

 
 Ben Atwell    +44 (0)20 3727 1000 
 

About Hikma

Hikma helps put better health within reach every day for millions of people in more than 50 countries around the world. For more than 40 years, we've been creating high-quality medicines and making them accessible to the people who need them. Headquartered in the UK, we are a global company with a local presence across the United States (US), the Middle East and North Africa (MENA) and Europe, and we use our unique insight and expertise to transform cutting-edge science into innovative solutions that transform people's lives. We're committed to our customers, and the people they care for, and by thinking creatively and acting practically, we provide them with a broad range of branded and non-branded generic medicines. Together, our 8,400 colleagues are helping to shape a healthier world that enriches all our communities. We are a leading licensing partner, and through our venture capital arm, are helping bring innovative health technologies to people around the world. For more information, please visit: www.hikma.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

NORGZGGZLDKGGZG

(END) Dow Jones Newswires

February 04, 2020 04:07 ET (09:07 GMT)

La tua Cronologia
BIT
BMPS
Monte Pasc..
BITI
FTSEMIB
FTSE Mib
BIT
UCG
Unicredit
NASDAQ
AAPL
Apple
FX
EURUSD
Euro vs Do..
Le azioni che visualizzerai appariranno in questo riquadro, così potrai facilmente tornare alle quotazioni di tuo interesse.

Registrati ora per creare la tua watchlist personalizzata in tempo reale streaming.

Per accedere al tempo reale push di Borsa è necessario registrarsi.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V:it D:20200526 01:01:25